title: A kinetic model identifies phosphorylated estrogen receptor-α (ERα) as a critical regulator of ERα dynamics in breast cancer.
abstract: Receptor levels are a key mechanism by which cells regulate their response to stimuli. The levels of estrogen receptor-α (ERα) impact breast cancer cell proliferation and are used to predict prognosis and sensitivity to endocrine therapy. Despite the clinical application of this information, it remains unclear how different cellular processes interact as a system to control ERα levels. To address this question, experimental results from the ERα-positive human breast cancer cell line (MCF-7) treated with 17-β-estradiol or vehicle control were used to develop a mass-action kinetic model of ERα regulation. Model analysis determined that RNA dynamics could be captured through phosphorylated ERα (pERα)-dependent feedback on transcription. Experimental analysis confirmed that pERα-S118 binds to the estrogen receptor-1 (ESR1) promoter, suggesting that pERα can feedback on ESR1 transcription. Protein dynamics required a separate mechanism in which the degradation rate for pERα was 8.3-fold higher than nonphosphorylated ERα. Using a model with both mechanisms, the root mean square error was 0.078. Sensitivity analysis of this combined model determined that while multiple mechanisms regulate ERα levels, pERα-dependent feedback elicited the strongest effect. Combined, our computational and experimental results identify phosphorylation of ERα as a critical decision point that coordinates the cellular circuitry to regulate ERα levels.
authors: *Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA; Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA; and University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
authors: Dan
authors: D
authors: Tian
authors: *Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA; Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA; and University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
authors: Natalia M
authors: NM
authors: Solodin
authors: *Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA; Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA; and University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
authors: Prashant
authors: P
authors: Rajbhandari
authors: *Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA; Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA; and University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
authors: Kelsi
authors: K
authors: Bjorklund
authors: *Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA; Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA; and University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
authors: Elaine T
authors: ET
authors: Alarid
authors: *Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA; Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA; and University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA kreeger@wisc.edu.
authors: Pamela K
authors: PK
authors: Kreeger
mesh_terms: D015153:Blotting, Western; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D047369:Chromatin Immunoprecipitation; D004958:Estradiol / Q000494:pharmacology*; D047628:Estrogen Receptor alpha / Q000235:genetics* / Q000378:metabolism*; D004967:Estrogens / Q000494:pharmacology; D025461:Feedback, Physiological; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D007700:Kinetics; D008962:Models, Theoretical; D010766:Phosphorylation / Q000187:drug effects; D011401:Promoter Regions, Genetic / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014158:Transcription, Genetic / Q000235:genetics; D014407:Tumor Cells, Cultured
chemical_list: C506487:ESR1 protein, human; D047628:Estrogen Receptor alpha; D004967:Estrogens; D012333:RNA, Messenger; D004958:Estradiol
keywords: feedback; mathematical modeling; nuclear receptor; systems biology
references: Mol Cell Biol. 2005 Jun;25(11):4349-58
references: 15899841
references: Crit Rev Eukaryot Gene Expr. 2002;12(1):1-22
references: 12433063
references: Int J Cancer. 1994 Oct 1;59(1):17-9
references: 7927897
references: J Clin Oncol. 1999 May;17(5):1474-81
references: 10334533
references: Breast Cancer Res Treat. 1998;51(3):227-38
references: 10068081
references: J Mol Endocrinol. 2008 Jan;40(1):23-34
references: 18096994
references: Endocr Relat Cancer. 2004 Dec;11(4):643-58
references: 15613444
references: Mol Endocrinol. 1999 Sep;13(9):1522-34
references: 10478843
references: Mol Cell Proteomics. 2009 Mar;8(3):467-80
references: 18984578
references: Int J Mol Sci. 2012;14(1):108-45
references: 23344024
references: Annu Rev Genet. 1991;25:89-123
references: 1667464
references: J Biol Chem. 1992 Apr 15;267(11):7263-8
references: 1559970
references: J Natl Cancer Inst. 1998 Jan 7;90(1):37-42
references: 9428781
references: Nat Biotechnol. 2002 Apr;20(4):370-5
references: 11923843
references: Nat Rev Cancer. 2014 Jan;14(1):26-38
references: 24505618
references: Wiley Interdiscip Rev Syst Biol Med. 2011 Mar-Apr;3(2):216-30
references: 21305704
references: Nat Rev Cancer. 2012 Jun;12(6):381-5
references: 22555282
references: PLoS One. 2012;7(5):e36559
references: 22606272
references: Am J Pathol. 1999 Dec;155(6):1811-5
references: 10595909
references: Biol Reprod. 1978 Mar;18(2):234-46
references: 630024
references: Cancer Res. 1991 Apr 1;51(7):1817-22
references: 2004366
references: Nat Rev Cancer. 2009 Sep;9(9):631-43
references: 19701242
references: Int J Breast Cancer. 2011;2011:232435
references: 22295213
references: J Biol Chem. 1999 Oct 15;274(42):30169-81
references: 10514507
references: Genes Dev. 2011 Dec 1;25(23):2502-12
references: 22156210
references: Ecancermedicalscience. 2013 Nov 05;7:370
references: 24222786
references: Genes Dev. 1988 Jun;2(6):754-65
references: 3138163
references: Br Med J (Clin Res Ed). 1988 May 14;296(6633):1349-51
references: 3134982
references: Adv Drug Deliv Rev. 2010 Oct 30;62(13):1265-76
references: 20708050
references: Mol Cell Biol. 2009 Sep;29(18):4949-58
references: 19620290
references: Nature. 2011 May 19;473(7347):337-42
references: 21593866
references: Dev Biol. 2009 Jan 15;325(2):317-28
references: 19028486
references: Mol Endocrinol. 2003 Oct;17(10):2013-27
references: 12855746
references: Endocr Rev. 1999 Jun;20(3):358-417
references: 10368776
references: J Clin Oncol. 2011 Aug 1;29(22):2978-84
references: 21709197
references: Nat Rev Cancer. 2011 Jul;11(7):523-32
references: 21677677
references: Mol Cell Biol. 2005 Jul;25(13):5417-28
references: 15964799
references: Clin Cancer Res. 2010 May 15;16(10):2702-8
references: 20427689
references: Cancer Manag Res. 2014 May 23;6:225-52
references: 24904222
references: J Cell Sci. 2002 Oct 15;115(Pt 20):3865-71
references: 12244124
references: Nat Cell Biol. 2006 Nov;8(11):1195-203
references: 17060902
references: PLoS One. 2009;4(4):e4901
references: 19381343
references: Mol Cell. 2000 Jul;6(1):127-37
references: 10949034
references: Mol Endocrinol. 1989 Feb;3(2):295-304
references: 2785242
references: Mol Endocrinol. 2006 Sep;20(9):1972-81
references: 16423879
references: J Steroid Biochem. 1987;27(1-3):171-6
references: 3695478
references: Arch Pathol Lab Med. 2010 Jun;134(6):907-22
references: 20524868
references: Oncogene. 2014 Mar 13;33(11):1438-47
references: 23542176
references: EMBO J. 1993 Mar;12(3):1153-60
references: 8458328
references: Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):867-72
references: 10548314
references: J Clin Invest. 2006 Mar;116(3):561-70
references: 16511588
references: FEBS Lett. 2013 Oct 11;587(20):3327-34
references: 23994522
references: Int J Cancer. 2013 Jul;133(1):1-13
references: 23280579
references: Nature. 2002 Apr 4;416(6880):499-506
references: 11932736
references: Endocr Rev. 2011 Oct;32(5):597-622
references: 21680538
references: Mol Endocrinol. 2005 Apr;19(4):833-42
references: 15695368
references: Mol Syst Biol. 2009;5:239
references: 19156131
references: Pharmacol Rev. 2001 Mar;53(1):25-71
references: 11171938
references: Curr Med Chem. 2013;20(5):596-604
references: 23278394
references: Cell. 1988 Oct 7;55(1):145-56
references: 3167974
references: BMC Syst Biol. 2012;6:138
references: 23134774
references: Breast. 2011 Oct;20 Suppl 3:S42-9
references: 22015292
references: Eur J Cancer. 1993;29A(7):971-7
references: 8499151